Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from OncoSil Medical Ltd ( (AU:OSL) ) is now available.
OncoSil Medical Ltd has announced a change in the director’s interest, with Lelde Smits acquiring 7,500 options under the company’s Long-Term Incentive (LTI) Scheme. This acquisition reflects the company’s ongoing efforts to align its leadership’s interests with long-term strategic goals, potentially impacting the company’s governance and stakeholder confidence.
More about OncoSil Medical Ltd
OncoSil Medical Ltd is a company operating in the medical industry, focusing on the development and commercialization of innovative medical devices. The company is primarily involved in creating products aimed at improving cancer treatment outcomes, with a focus on delivering targeted radiation therapy solutions.
Average Trading Volume: 35,776
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$13.79M
For detailed information about OSL stock, go to TipRanks’ Stock Analysis page.